BackBack Shiva Pharmachem files DRHP to raise ₹900 crore via IPO
Written by: Planify
Published: 22 August 2023
Updated: 22 February 2024
1 min read
Specialty chemicals manufacturer Shiva Pharmachem plans to raise ₹900 crore from the primary market and has filed preliminary papers for its maiden public issue. The Vadodara-based Shiva Pharmachem has filed its Draft Red Herring prospectus (DRHP) with the capital market regulator Securities & Exchange Board of India (SEBI) for an initial public offering (IPO).
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
